Updates in the Myelodysplastic Syndromes: 2023 Best of Hematology

Dr Aditi Shastri from Montefiore Medical Center comments on updates in classification, prognostication, and treatment for MDS: Incorporating molecular parameters into the IPSS-M for more efficient use of targeted therapies, expanding treatment options for low-risk and high risk MDS patients.